ORLANDO — With the recent approval of Allergan’s Vuity presbyopia-correcting eye drop, many patients have been asking their ophthalmologists about the drop’s availability and effectiveness, and a panel discussed their experience here.
During a panel on presbyopia-correcting technologies at Cataract Surgery: Telling It Like It Is, William B. Trattler, MD, said, “We are seeing a really strong demand in our practice for drops. I’m interested in what discussions the panel is hearing from their patients and their thoughts.”
“We definitely have patients